FR2118862A2 - Oral dosage forms of succinimide - for prevention and cure of lithiasis due to oxalic acid - Google Patents

Oral dosage forms of succinimide - for prevention and cure of lithiasis due to oxalic acid

Info

Publication number
FR2118862A2
FR2118862A2 FR7046611A FR7046611A FR2118862A2 FR 2118862 A2 FR2118862 A2 FR 2118862A2 FR 7046611 A FR7046611 A FR 7046611A FR 7046611 A FR7046611 A FR 7046611A FR 2118862 A2 FR2118862 A2 FR 2118862A2
Authority
FR
France
Prior art keywords
oxalic acid
succinimide
lithiasis
cure
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7046611A
Other languages
English (en)
French (fr)
Other versions
FR2118862B2 (show.php
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAUBA LAB
Original Assignee
SAUBA LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAUBA LAB filed Critical SAUBA LAB
Priority to FR7046611A priority Critical patent/FR2118862A2/fr
Publication of FR2118862A2 publication Critical patent/FR2118862A2/fr
Application granted granted Critical
Publication of FR2118862B2 publication Critical patent/FR2118862B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7046611A 1970-12-24 1970-12-24 Oral dosage forms of succinimide - for prevention and cure of lithiasis due to oxalic acid Granted FR2118862A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7046611A FR2118862A2 (en) 1970-12-24 1970-12-24 Oral dosage forms of succinimide - for prevention and cure of lithiasis due to oxalic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7046611A FR2118862A2 (en) 1970-12-24 1970-12-24 Oral dosage forms of succinimide - for prevention and cure of lithiasis due to oxalic acid

Publications (2)

Publication Number Publication Date
FR2118862A2 true FR2118862A2 (en) 1972-08-04
FR2118862B2 FR2118862B2 (show.php) 1974-03-22

Family

ID=9066337

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7046611A Granted FR2118862A2 (en) 1970-12-24 1970-12-24 Oral dosage forms of succinimide - for prevention and cure of lithiasis due to oxalic acid

Country Status (1)

Country Link
FR (1) FR2118862A2 (show.php)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
FR2118862B2 (show.php) 1974-03-22

Similar Documents

Publication Publication Date Title
Israel Premenstrual tension
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
ATA84882A (de) Therapeutisches abgabesystem zur verabreichung eines wirkstoffes durch die haut
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
FI905718A0 (fi) Transdermalt medel.
RU94046316A (ru) Применение высокоэффективных фосфонатов при изготовлении лекарственных средств для лечения остеопороза
DE3789239D1 (de) Pharmazeutische Zusammensetzung enthaltend Interferon für bukkale Verabreichung.
Grob et al. Corticotropin in generalized myasthenia gravis: Effect of short, intensive courses
ZA884670B (en) Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process
CA982478A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
JPS55136229A (en) Adjustment of bone metabolism in warm-blooded animal and drug for it
IT1153487B (it) Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
FR2437834A1 (fr) Compositions pharmaceutiques a base de l-serine ou de glycine
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
Escobar et al. Treatment of phobic neurosis with clomipramine: a controlled clinical trial.
FR2118862A2 (en) Oral dosage forms of succinimide - for prevention and cure of lithiasis due to oxalic acid
EG10421A (en) Process for preparation of phenyl acetic acid and it's derivatives,used for treatment inflamation,sedative and antipyrtic
PT65737B (en) Process for the preparation of disubstituted phenol ethersof 3-amino-2-hydroxypropane with cerebrovascular activity application of same for the preparation of pharmaceutical compositions with cerebrovascular activity and applicationof these pharmaceutical compositions in the treatment of cerebrovascular insufficiency
AR002946A1 (es) Un conjunto para uso en el tratamiento o la prevencion de la osteoporosis en los mamiferos de acuerdo con una dieta ciclica.
BE783494A (fr) Composition et procede pour le traitement d'affections pulmonaires au moyen d'inhalations.
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
FR2298320A1 (fr) Compositions pharmaceutiques renfermant de l'hydrazide de n-benze
KR880009652A (ko) 3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물
GB1472086A (en) Pharmaceutical composition for treatment of liver diseases
Thomas Loxapine oral liquid concentrate in the treatment of young adult patients with acute schizophrenic symptoms.